论文投稿时需要用到的八种沟通信件模板

2018.10.25 14:39
646 0 0

  在我们投稿国外SCI时一般都是全程英文沟通,由于论文投稿过程步骤多、耗时长,我们常常需要和编辑进行沟通,今天为大家带来的是论文投稿时最常用到的八种沟通信件模板,希望能帮助到大家。

  1. cover letter(投稿信)

  SCI论文投稿时为了提高录用率,通常都会写一份cover letter。cover letter的作用是有助于稿件被送到合适的编辑和评审人手中。如果没有cover letter,稿件可能会给编辑造成一些困扰:

  • 这篇稿件是投给哪种期刊的?

  • 何种栏目?

  • 是新稿还是修改稿?

  • 如果是修改稿的话,是哪位编辑负责的?

  • 如果这篇稿件有多位作者的话,哪一位是通讯作者?

  • 通讯作者的联系地址是什么?

  因此,为了减少给编辑造成的困扰,一份合格的cover letter非常重要。

  cover letter的内容必须能够激励编辑继续去读你的文章全文。因此,你工作中的重要内容(例如创新性和在研究领域的意义)需要在cover letter中呈现出来。一般情况下,cover letter的长度在5段以内。太短不足以充分表达文章所做工作的重点内容,太长会让编辑感觉作者心虚。

  一份cover letter通常包括的内容是:

  1. 向编辑简要介绍一下论文的内容和参与此项研究工作的作者名单。这里不需要太详细,即使是工作中包含了一些复杂的实验部分。

  2. 重点解释为什么该研究是创新性的,并且大家会对此感兴趣。

  这里,你可以介绍论文中用到哪些创新性的技术,你的实验样本数量足够多,研究成果将对这个领域有较大影响等。如果你投的是临床国际期刊,你还要介绍这项工作会对将来的实际治疗应用有什么意义。

  此处有2点需要你重点注意:

  • 写作时包含要点但不用仔细解释;

  • 尽量让编辑看到你的工作和所投期刊非常相关;

  • 最好,你的工作也刚好验证了别的研究团队在这个期刊前期发表的成果,或者与他们结果相反。

  3. 介绍你和你的研究团队:主要研究人员、实验室的研究方向和这篇文章的关系。解释为什么要选择投这个期刊。如果其他实验室与你的研究团队合作完成此项工作,你最好也要介绍一下相关合作团队。

  4. 声明你的文章没有任何利益方面的冲突。因为每个期刊有不同的相关规定,所以查询一下各个期刊在利益冲突政策方面的描述。同时,一定要声明这项研究没有在其他期刊投稿和发表过。

  上面是写在cover letter中的要点,下面说一下有哪些内容不能写在cover letter中:

  1. 不要在没有任何证明或引用情况下提及过去的发表文献。

  2. 不要提供与投稿无关的个人信息。

  3. 除非和这次的研究问题有关,否则不要提到您或者其他共同作者先前的发表记录。

  4. 不要复制粘贴上摘要的内容。

  5. 不要使用复杂发散的句构以免造成不必要的困惑。

  下面我举2个成功的cover letter样式给大家参考:

  例子1:投稿《欧洲心血管病杂志》

  Dear editorial board of European Journal of Cardiology,

  Please find enclosed the manuscript: “The angiotensin-converting enzyme is not a risk factor for myocardial infarction in French individuals”, by Sarah H., et al., to be submitted as a Short Communication to the European Journal of Neurology for consideration of publication. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report. We certify that the submission is original work and is not under review at any other publication.

  In this manuscript, we report the results of the first study on the genetic and functional roles of the ACE on the risk of suffering a myocardial infarction in the French population. Indeed, we genotyped the rs4341 polymorphism in 531 IS cases and 549 healthy controls, and then performed functional studies by measuring serum ACE protein level and activity in healthy controls, stroke patients at baseline and stroke patients 24h after stroke symptoms onset. The results from our study did not reveal any association of the ACE variant with myocardial infarction, although it affected ACE protein level, and ischemic stroke patients showed lower ACE level than controls in the acute phase but not in the chronic phase.

  We believe that our findings could be of interest to the readers of European Journal of Cardiology because they bring new and strong evidence that the ACE gene and protein are not a risk factor for myocardial infarction.

  We hope that the editorial board will agree on the interest of this study.

  Sincerely yours,

  Sarah H. on behalf of the authors.

  Corresponding author: Sarah Hamilton at Cardiovascular Research Laboratory, Marie Curie Research Institute, 75000, Paris, France, xxx@mariecurie.fr, phone number: +33582246xxx, fax number: +33582246xxx.

  例子2:投稿《临床化学》

  Dear Dr Broderick,

  Please find enclosed the manuscript: Association between Estrogen Receptor Alpha (ESR1) genetic variants and risk of Stroke, by Sarah H., Isaac S., Marta L., Marc C. and Julien S. to be submitted as an new article to Clinical Chemistry.

  In this manuscript, we report the results of a nested case-control study in a French population on the risk of suffering an ischemic stroke associated with genetic variants in the gene coding for the protein Estrogen Receptor Alpha.

  We believe that our findings could be of interest to the readers of Clinical Chemistry because they replicate partially the results observed by Rexrode et al. in a white American population and published in Clinical Chemistry in October 2007. Indeed, we demonstrate an association of the rs1271673 SNP T variant and a very common haplotype encompassing the rs1271673 variant with an increased risk of ischemic stroke.

  We hope that the editorial board and the reviewers will agree on the interest of this study.

  Sincerely yours,

  Sarah H..

  2. 催稿信

  通常写催稿信是因为,你投稿后收到编辑回信,说已经指定了审稿人,之后是漫长的等待,你很着急,于是就给编辑部写了催稿信。

  Dear Prof. ×××:

  Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of my submitted manuscript titled “Paper Title”. (ID: 文章稿号), although the status of “With Editor” has been lasting for more than two months, since submitted to journal three months ago. I am just wondering that my manuscript has been sent to reviewers or not?

  I would be greatly appreciated if you could spend some of your time check the status for us. I am very pleased to hear from you on the reviewer’s comments.

  Thank you very much for your consideration.

  Best regards!

  Yours sincerely,

  ××××××

  Corresponding author:

  Name: ×××

  E-mail: ××××@××××

  3. 修改后投稿的cover letter(投稿信)

  根据编辑部和审稿人的意见对稿件进行修改,完成后重新投稿时,也要附上一封cover letter,但是这封cover letter和刚投稿时的cover letter又不一样。

  Dear Dr/ Prof..(写上负责你文章编辑的姓名,显得尊重,因为第一次的投稿不知道具体负责的编辑,只能用通用的Editors):

  On behalf of my co-authors, we thank you very much for giving us an opportunity to revise our manuscript, we appreciate editor and reviewers very much for their positive and constructive comments and suggestions on our manuscript entitled “Paper Title”. (ID: 文章稿号).

  We have studied reviewer’s comments carefully and have made revision which marked in red in the paper. We have tried our best to revise our manuscript according to the comments. Attached please find the revised version, which we would like to submit for your kind consideration.

  We would like to express our great appreciation to you and reviewers for comments on our paper. Looking forward to hearing from you.

  Thank you and best regards.

  Yours sincerely,

  ××××××

  Corresponding author:

  Name: ×××

  E-mail: ××××@××××

  4. 回答审稿人的修改意见

  根据审稿人意见修改后,必须要给出你在哪些地方进行了什么样的修改,因此这封信很重要。

  Dear Editors and Reviewers:

  Thank you for your letter and for the reviewers’ comments concerning our manuscript entitled “Paper Title” (ID: 文章稿号). Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our researches. We have studied comments carefully and have made correction which we hope meet with approval. Revised portion are marked in red in the paper. The main corrections in the paper and the responds to the reviewer’s comments are as flowing:

  Responds to the reviewer’s comments:

  Reviewer #1:

  1. Response to comment: (……简要列出意见……)

  Response: ××××××

  2. Response to comment: (……简要列出意见……)

  Response: ××××××

  ...

  逐条意见回答,切忌一定不能有遗漏,针对不同的问题可以使用下列几个礼貌术语:

  We are very sorry for our negligence of ……...

  It is really true as Reviewer suggested that……

  We have made correction according to the Reviewer’s comments.

  Considering the Reviewer’s suggestion, we have ……

  最后特意感谢一下这个审稿人的意见:

  Special thanks to you for your good comments.

  Reviewer #2:

  同上述。

  Other changes:

  1. Line 60-61, the statements of “……” were corrected as “…………”

  2. Line 107, “……” was added.

  ......

  We tried our best to improve the manuscript and made some changes in the manuscript. These changes will not influence the content and framework of the paper. And here we did not list the changes but marked in red in revised paper.

  We appreciate for Editors/Reviewers’ warm work earnestly, and hope that the correction will meet with approval.

  Once again, thank you very much for your comments and suggestions.

  5. 致谢信

  论文录用后,为了表示你的礼貌,可以给编辑老师发一份感谢谢。

  Dear Prof. ××××××:

  Thanks very much for your kind work and consideration on publication of our paper. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

  Thank you and best regards.

  Yours sincerely,

  ××××××

  Corresponding author:

  Name: ×××

  E-mail: ××××@××××

  6. 询问校稿

  文章接受了,可是长时间没有收到校稿通知,这时候可以写信问一下编辑老师。

  Dear ×××:

  Sorry for disturbing you. I am not sure if it is the right time to contact you to inquire about the status of our accepted manuscript titled “Paper Title” (ID: 文章稿号), since the copyright agreement for publication has been sent to you two months ago. I am just wondering that how long I can receive the proof of our manuscript from you?

  I would be greatly appreciated if you could spend some of your time for a reply. I am very pleased to hear from you.

  Thank you very much for your consideration.

  Yours sincerely,

  ××××××

  Corresponding author:

  Name: ×××

  E-mail: ××××@××××

  7. 文章校稿

  已经录用的文章开始校稿,需要不停地与编辑部进行沟通,过程中来往的信件非常频繁,也非常重要。

  Dear Mr. ×××:

  Thanks very much for your kind letter about the proof of our paper titled “Paper Title” (ID: 文章稿号) for publication in “Journal Name”. We have finished the proof reading and checking carefully, and some corrections about the proof and the answers to the queries are provided below.

  Corrections:

  1. In ****** should be **** (Page ***, Right column, line***)

  2. In **** the “*****” should be “****” (Page ****, Right column, line****)

  Answers for “author queries”:

  1. *********************.

  2. **********************

  3. **********************

  We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know.

  Thank you and best regards.

  Yours sincerely,

  ××××××

  Corresponding author:

  Name: ×××

  E-mail: ××××@××××

  8. 要求减免版面费

  文章已经接受,需要提交版面费,但是你觉得版面费太多了,你可以发一封邮件与出版社进行沟通,有可能最后就将你的版面费减免了。

  Dear Editor

  We are glad to see that our paper will be published in ××××. Thanks a million for your work. Although we have been supported by an external grant source, we must admit that it is not enough money to pay page charges. We hope to waive page charges expect for payments for language corrections and color figures.

  Best wishes.

  ××××××

  Corresponding author:

  Name: ×××

  E-mail: ××××@××××


标签: 论文投稿
投诉文章 ©著作权归作者所有
喜欢  |  0
0/200字
没有更多评论了~
悬赏问题
给科研问题设置一定金额,将更容易获得关注与回答哦~
  • 1元
  • 3元
  • 5元
  • 8元
  • 18元
  • 自定义
选择支付方式
  • 微信支付
  • 支付宝支付
  • 余额支付

旗下网站

晟斯医学- 临床医生学术科研发展平台 2014-2019 晟斯医学版权所有
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司